NASDAQ:AQB Aquabounty Technologies Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Aquabounty Technologies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $5.16 +0.66 (+14.67 %) (As of 09/18/2020 12:00 AM ET) Add Compare Share Today's Range$4.50Now: $5.16▼$5.2550-Day Range$2.49MA: $3.09▼$4.5052-Week Range$1.52Now: $5.16▼$5.25Volume3.54 million shsAverage Volume329,872 shsMarket Capitalization$165.77 millionP/E RatioN/ADividend YieldN/ABeta1.02 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media AquaBounty Technologies, Inc., a biotechnology company, develops and markets products to enhance productivity in aquaculture. It offers AquAdvantage Salmon, a genetically modified Atlantic salmon for human consumption. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was founded in 1991 and is headquartered in Maynard, Massachusetts. AquaBounty Technologies, Inc. is a subsidiary of Intrexon Corporation.Read More Beat the Market (BTM) Rank™ 1.5 Analyst's Opinion Consensus RatingAquabounty Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $4.50, Aquabounty Technologies has a forecasted downside of 12.8% from its current price of $5.16.Amount of Analyst CoverageAquabounty Technologies has only been the subject of 1 research reports in the past 90 days. Previous Next 2.5 Community Rank Outperform VotesAquabounty Technologies has received 175 “outperform” votes. (Add your “outperform” vote.)Underperform VotesAquabounty Technologies has received 180 “underperform” votes. (Add your “underperform” vote.)Community SentimentAquabounty Technologies has received 50.70% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Aquabounty Technologies and other stocks. Vote “Outperform” if you believe AQB will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AQB will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldAquabounty Technologies does not currently pay a dividend.Dividend GrowthAquabounty Technologies does not have a long track record of dividend growth. Previous Next 4.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Aquabounty Technologies insiders have bought more of their company's stock than they have sold. Specifically, they have bought $10,023,000.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 2.50% of the stock of Aquabounty Technologies is held by insiders.Percentage Held by Institutions60.63% of the stock of Aquabounty Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Aquabounty Technologies are expected to grow in the coming year, from ($0.38) to ($0.25) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Aquabounty Technologies is -9.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aquabounty Technologies is -9.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAquabounty Technologies has a P/B Ratio of 4.69. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 1.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.73 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Fishing, hunting & trapping Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AQB Previous Symbol CUSIPN/A CIK1603978 Webwww.aquabounty.com Phone978-648-6000Debt Debt-to-Equity Ratio0.15 Current Ratio6.74 Quick Ratio5.48Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$190,000.00 Price / Sales872.45 Cash FlowN/A Price / Cash FlowN/A Book Value$1.10 per share Price / Book4.69Profitability EPS (Most Recent Fiscal Year)($0.66) Net Income$-13,230,000.00 Net MarginsN/A Return on Equity-44.53% Return on Assets-36.54%Miscellaneous Employees39 Outstanding Shares32,125,000Market Cap$165.77 million Next Earnings Date11/3/2020 (Estimated) OptionableNot Optionable $5.16 +0.66 (+14.67 %) (As of 09/18/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive AQB News and Ratings via Email Sign-up to receive the latest news and ratings for AQB and its competitors with MarketBeat's FREE daily newsletter. Aquabounty Technologies (NASDAQ:AQB) Frequently Asked Questions How has Aquabounty Technologies' stock price been impacted by COVID-19? Aquabounty Technologies' stock was trading at $1.85 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AQB stock has increased by 178.9% and is now trading at $5.16. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of Aquabounty Technologies? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aquabounty Technologies in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Aquabounty Technologies. When is Aquabounty Technologies' next earnings date? Aquabounty Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020. View our earnings forecast for Aquabounty Technologies. How were Aquabounty Technologies' earnings last quarter? Aquabounty Technologies Inc (NASDAQ:AQB) issued its earnings results on Thursday, August, 6th. The company reported ($0.11) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.11). View Aquabounty Technologies' earnings history. What price target have analysts set for AQB? 3 brokers have issued 12 month price targets for Aquabounty Technologies' stock. Their forecasts range from $3.50 to $5.00. On average, they expect Aquabounty Technologies' stock price to reach $4.50 in the next twelve months. This suggests that the stock has a possible downside of 12.8%. View analysts' price targets for Aquabounty Technologies. Are investors shorting Aquabounty Technologies? Aquabounty Technologies saw a decrease in short interest in the month of August. As of August 31st, there was short interest totaling 367,200 shares, a decrease of 11.2% from the August 15th total of 413,400 shares. Based on an average trading volume of 551,300 shares, the short-interest ratio is currently 0.7 days. Currently, 4.8% of the company's stock are short sold. View Aquabounty Technologies' Short Interest. Who are some of Aquabounty Technologies' key competitors? Some companies that are related to Aquabounty Technologies include Endo International (ENDP), Cryolife (CRY), Syndax Pharmaceuticals (SNDX), Osiris Therapeutics (OSIR), AC Immune (ACIU), Relmada Therapeutics (RLMD), Relmada Therapeutics (RLMD), Autolus Therapeutics (AUTL), Allovir (ALVR), Inogen (INGN), Accelerate Diagnostics (AXDX), Checkmate Pharmaceuticals (INBX), Invo Bioscience (IVOB), Aprea Therapeutics (APRE) and Tactile Systems Technology (TCMD). View all competitors. What other stocks do shareholders of Aquabounty Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aquabounty Technologies investors own include Precigen (PGEN), Celldex Therapeutics (CLDX), ZIOPHARM Oncology (ZIOP), AbbVie (ABBV), Ocular Therapeutix (OCUL), AT&T (T), Vistagen Therapeutics (VTGN), Allena Pharmaceuticals (ALNA), Crispr Therapeutics (CRSP) and Energy Transfer LP Unit (ET). Who are Aquabounty Technologies' key executives? Aquabounty Technologies' management team includes the following people: Mr. David A. Frank, CFO & Treasurer (Age 59)Dr. Ronald L. Stotish, Exec. Director & Chief Technology Officer (Age 70)Mr. Alejandro Rojas, Chief Operating Officer of Aquabounty Farms (Age 57)Ms. Sylvia Wulf, CEO, Pres & Exec. Director (Age 61)Mr. Christopher H. Martin, Gen. Counsel & Company Sec. (Age 53) What is Aquabounty Technologies' stock symbol? Aquabounty Technologies trades on the NASDAQ under the ticker symbol "AQB." Who are Aquabounty Technologies' major shareholders? Aquabounty Technologies' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Epiq Partners LLC (2.03%), Sumitomo Mitsui Trust Holdings Inc. (0.62%), Advisor Group Holdings Inc. (0.47%), UBS Group AG (0.07%), Cambridge Investment Research Advisors Inc. (0.05%) and Raymond James Financial Services Advisors Inc. (0.04%). Company insiders that own Aquabounty Technologies stock include David A Frank, Randal J Kirk and Rick L Sterling. View institutional ownership trends for Aquabounty Technologies. Which major investors are selling Aquabounty Technologies stock? AQB stock was sold by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., UBS Group AG, and Cambridge Investment Research Advisors Inc.. View insider buying and selling activity for Aquabounty Technologies. Which major investors are buying Aquabounty Technologies stock? AQB stock was acquired by a variety of institutional investors in the last quarter, including Advisor Group Holdings Inc., Epiq Partners LLC, and Raymond James Financial Services Advisors Inc.. Company insiders that have bought Aquabounty Technologies stock in the last two years include David A Frank, Randal J Kirk, and Rick L Sterling. View insider buying and selling activity for Aquabounty Technologies. How do I buy shares of Aquabounty Technologies? Shares of AQB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Aquabounty Technologies' stock price today? One share of AQB stock can currently be purchased for approximately $5.16. How big of a company is Aquabounty Technologies? Aquabounty Technologies has a market capitalization of $165.77 million and generates $190,000.00 in revenue each year. The company earns $-13,230,000.00 in net income (profit) each year or ($0.66) on an earnings per share basis. Aquabounty Technologies employs 39 workers across the globe. What is Aquabounty Technologies' official website? The official website for Aquabounty Technologies is www.aquabounty.com. How can I contact Aquabounty Technologies? Aquabounty Technologies' mailing address is 2 MILL & MAIN PLACE SUITE 395, MAYNARD MA, 01754. The company can be reached via phone at 978-648-6000 or via email at [email protected] This page was last updated on 9/20/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
